PSMD12通过稳定CDK1促进肝细胞癌的进展
Xingyu Peng1,2, Zitao Liu1,2, Chen Luo3
1Department of General Surgery, The 2nd Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Frontiers in immunology
|June 19, 2025
概括
蛋白质素26S亚基非ATPase12 (PSMD12) 在肝细胞癌 (HCC) 中被上调,促进瘤生长和不良预后. 针对PSMD12可能为HCC患者提供新的治疗策略.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 生物化学 生物化学
背景情况:
- 蛋白酶体系统维持了蛋白质的稳态.
- 蛋白酶26S非ATPase12 (PSMD12) 子单元在肝细胞癌 (HCC) 中的特定作用尚不清楚.
- 了解PSMD12在HCC中的功能对于确定新的治疗点至关重要.
研究的目的:
- 研究PSMD12在肝细胞癌 (HCC) 中的作用.
- 确定PSMD12是否可以作为HCC的预后生物标志物和治疗标.
主要方法:
- 生物信息学分析
- 免疫组织化学 免疫组织化学
- 西方涂抹是指西方涂抹.
- qRT-PCR 是一个很好的方法.
- 功能性检测 (细胞增殖,迁移,细胞循环分析)
- 同免疫沉以研究蛋白质相互作用.
主要成果:
- 与正常肝脏组织相比,PSMD12在HCC组织中显著上调.
- 高PSMD12表达与患者预后不佳相关.
- 通过PSMD12 Knockdown抑制HCC细胞的增殖和迁移,导致G2/M细胞循环停止.
- PSMD12过度表达增强了HCC细胞恶性行为.
- PSMD12与CDK1相互作用,抑制其降解并促进细胞循环的进展.
结论:
- 在促进HCC进展方面,PSMD12起着至关重要的作用.
- PSMD12通过稳定CDK1而起作用,从而加速细胞循环的进展.
- PSMD12是一种潜在的预后生物标志物和肝细胞癌的治疗标.
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
MAPK Signaling Cascades
6.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.2K
M-Cdk Drives Transition Into Mitosis
5.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K
Positive Regulator Molecules
5.7K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.7K
Interactions Between Signaling Pathways
6.6K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K


